Cigna Q1 2024 Earnings Report
Key Takeaways
The Cigna Group reported strong first quarter 2024 results driven by the performance of Evernorth and Cigna Healthcare. The company increased its outlook for full-year earnings.
Shareholders’ net loss for first quarter 2024 was $0.3 billion, or $0.97 per share, including a non-cash after-tax investment loss of $1.8 billion, or $6.31 per share, related to the impairment of VillageMD equity securities.
Adjusted income from operations for first quarter 2024 was $1.9 billion, or $6.47 per share.
The sale of our Medicare businesses to HCSC remains on track with the expiration of the waiting period under the Hart-Scott Rodino Act having occurred on April 17.
The transaction is expected to close in the first quarter of 2025.
Cigna
Cigna
Forward Guidance
The Cigna Group's outlook for full year 2024 adjusted revenues is at least $235.0 billion. The Cigna Group’s outlook for full year 2024 consolidated adjusted income from operations is at least $8.065 billion, or at least $28.40 per share. This outlook includes the impact of expected future share repurchases and anticipated 2024 dividends.